🇺🇸 FDA
Patent

US 10561666

Amido compounds as RORγt modulators and uses thereof

granted A61KA61K31/12A61K31/33

Quick answer

US patent 10561666 (Amido compounds as RORγt modulators and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/12, A61K31/33, A61K31/4025, A61K31/404